BPMC
Price
$87.51
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
102 days until earnings call
MDXG
Price
$6.85
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
121 days until earnings call
Ad is loading...

BPMC vs MDXG

Header iconBPMC vs MDXG Comparison
Open Charts BPMC vs MDXGBanner chart's image
Blueprint Medicines
Price$87.51
Change-$0.00 (-0.00%)
Volume$4.48K
CapitalizationN/A
MiMedx Group
Price$6.85
Change-$0.00 (-0.00%)
Volume$2.47K
CapitalizationN/A
View a ticker or compare two or three
BPMC vs MDXG Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BPMC vs. MDXG commentary
Nov 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Hold and MDXG is a Hold.

COMPARISON
Comparison
Nov 03, 2024
Stock price -- (BPMC: $87.51 vs. MDXG: $6.85)
Brand notoriety: BPMC and MDXG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 1% vs. MDXG: 0%
Market capitalization -- BPMC: $5.76B vs. MDXG: $1.02B
BPMC [@Biotechnology] is valued at $5.76B. MDXG’s [@Biotechnology] market capitalization is $1.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $494.31B to $0. The average market capitalization across the [@Biotechnology] industry is $2.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileMDXG’s FA Score has 1 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • MDXG’s FA Score: 1 green, 4 red.
According to our system of comparison, MDXG is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 6 TA indicator(s) are bullish while MDXG’s TA Score has 4 bullish TA indicator(s).

  • BPMC’s TA Score: 6 bullish, 4 bearish.
  • MDXG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BPMC is a better buy in the short-term than MDXG.

Price Growth

BPMC (@Biotechnology) experienced а +6.11% price change this week, while MDXG (@Biotechnology) price change was +17.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BPMC is expected to report earnings on Feb 13, 2025.

MDXG is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($5.76B) has a higher market cap than MDXG($1.02B). BPMC YTD gains are higher at: -5.128 vs. MDXG (-21.893). MDXG has higher annual earnings (EBITDA): 66.8M vs. BPMC (-159.72M). BPMC has more cash in the bank: 764M vs. MDXG (69M). MDXG has less debt than BPMC: MDXG (19.2M) vs BPMC (475M). BPMC has higher revenues than MDXG: BPMC (363M) vs MDXG (340M).
BPMCMDXGBPMC / MDXG
Capitalization5.76B1.02B566%
EBITDA-159.72M66.8M-239%
Gain YTD-5.128-21.89323%
P/E RatioN/A12.16-
Revenue363M340M107%
Total Cash764M69M1,107%
Total Debt475M19.2M2,474%
FUNDAMENTALS RATINGS
BPMC vs MDXG: Fundamental Ratings
BPMC
MDXG
OUTLOOK RATING
1..100
8234
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
7882
SMR RATING
1..100
9712
PRICE GROWTH RATING
1..100
5345
P/E GROWTH RATING
1..100
7792
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDXG's Valuation (65) in the Biotechnology industry is in the same range as BPMC (80). This means that MDXG’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (78) in the Biotechnology industry is in the same range as MDXG (82). This means that BPMC’s stock grew similarly to MDXG’s over the last 12 months.

MDXG's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for BPMC (97). This means that MDXG’s stock grew significantly faster than BPMC’s over the last 12 months.

MDXG's Price Growth Rating (45) in the Biotechnology industry is in the same range as BPMC (53). This means that MDXG’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's P/E Growth Rating (77) in the Biotechnology industry is in the same range as MDXG (92). This means that BPMC’s stock grew similarly to MDXG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCMDXG
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
72%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQJG22.940.21
+0.92%
Invesco ESG NASDAQ Next Gen 100 ETF
TDVI24.420.16
+0.64%
FT Cboe Vest Tech Div Trgt Inc ETF
IBMN26.570.01
+0.02%
iShares iBonds Dec 2025 Term Muni Bd ETF
IFRA46.90N/A
N/A
iShares US Infrastructure ETF
PCGG11.31N/A
N/A
Polen Capital Global Growth ETF

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with SNDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
N/A
SNDX - BPMC
46%
Loosely correlated
+0.64%
BBIO - BPMC
45%
Loosely correlated
N/A
ORMP - BPMC
44%
Loosely correlated
N/A
INZY - BPMC
43%
Loosely correlated
N/A
BEAM - BPMC
43%
Loosely correlated
N/A
More

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with AVXL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
N/A
AVXL - MDXG
51%
Loosely correlated
N/A
BEAM - MDXG
50%
Loosely correlated
N/A
RCKT - MDXG
49%
Loosely correlated
N/A
VCEL - MDXG
49%
Loosely correlated
-0.11%
RXRX - MDXG
49%
Loosely correlated
N/A
More